Calamos Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30M Sell
118,126
-2,826
-2% -$659K 0.91% 23
2026
Q1
$29.6M Sell
120,952
-6,096
-5% -$1.42M 1.02% 18
2025
Q4
$26.3M Sell
127,048
-926
-0.7% -$183K 0.91% 20
2025
Q3
$23.7M Buy
127,974
+7,843
+7% +$1.34M 0.86% 23
2025
Q2
$18.3M Buy
120,131
+3,737
+3% +$574K 0.78% 24
2025
Q1
$19.3M Buy
116,394
+15,447
+15% +$2.42M 0.96% 20
2024
Q4
$14.6M Buy
100,947
+58,424
+137% +$9.05M 0.73% 28
2024
Q3
$6.89M Sell
42,523
-311
-0.7% -$49.5K 0.35% 65
2024
Q2
$6.26M Buy
42,834
+7,557
+21% +$1.12M 0.33% 65
2024
Q1
$5.58M Buy
35,277
+4,536
+15% +$722K 0.31% 72
2023
Q4
$4.82M Buy
30,741
+10,280
+50% +$1.58M 0.3% 68
2023
Q3
$3.19M Buy
20,461
+1,453
+8% +$240K 0.24% 80
2023
Q2
$3.15M Sell
19,008
-244
-1% -$39.4K 0.23% 83
2023
Q1
$2.98M Sell
19,252
-364
-2% -$58.8K 0.23% 82
2022
Q4
$3.47M Buy
19,616
+121
+0.6% +$20.9K 0.27% 82
2022
Q3
$3.19M Sell
19,495
-2,590
-12% -$438K 0.27% 76
2022
Q2
$3.92M Sell
22,085
-205
-0.9% -$36.5K 0.35% 72
2022
Q1
$3.95M Buy
22,290
+1,557
+8% +$265K 0.3% 81
2021
Q4
$3.55M Sell
20,733
-1,219
-6% -$200K 0.26% 86
2021
Q3
$3.54M Sell
21,952
-655
-3% -$112K 0.29% 81
2021
Q2
$3.72M Buy
22,607
+448
+2% +$74.2K 0.29% 79
2021
Q1
$3.64M Buy
22,159
+1,352
+6% +$219K 0.3% 78
2020
Q4
$3.27M Buy
20,807
+5,414
+35% +$799K 0.3% 75
2020
Q3
$2.29M Buy
15,393
+301
+2% +$44.5K 0.26% 72
2020
Q2
$2.12M Sell
15,092
-1,226
-8% -$179K 0.26% 71
2020
Q1
$2.14M Sell
16,318
-10,236
-39% -$1.45M 0.33% 65
2019
Q4
$3.87M Sell
26,554
-1,036
-4% -$141K 0.46% 64
2019
Q3
$3.57M Sell
27,590
-3,409
-11% -$449K 0.48% 64
2019
Q2
$4.32M Sell
30,999
-2,389
-7% -$331K 0.58% 48
2019
Q1
$4.67M Sell
33,388
-40,583
-55% -$5.44M 0.67% 42
2018
Q4
$9.55M Sell
73,971
-6,847
-8% -$955K 1.44% 12
2018
Q3
$11.2M Sell
80,818
-4,232
-5% -$562K 1.39% 13
2018
Q2
$10.3M Buy
85,050
+505
+0.6% +$63K 1.29% 15
2018
Q1
$10.8M Buy
84,545
+990
+1% +$134K 1.36% 15
2017
Q4
$11.7M Buy
83,555
+1,047
+1% +$146K 1.51% 12
2017
Q3
$10.7M Buy
82,508
+6,547
+9% +$868K 1.49% 12
2017
Q2
$10M Buy
75,961
+11,869
+19% +$1.51M 1.42% 12
2017
Q1
$7.98M Buy
64,092
+2,121
+3% +$253K 1.19% 18
2016
Q4
$7.14M Sell
61,971
-279
-0.4% -$32.2K 1.15% 17
2016
Q3
$7.35M Buy
62,250
+2,340
+4% +$284K 1.26% 14
2016
Q2
$7.27M Buy
59,910
+3,111
+5% +$353K 1.28% 14
2016
Q1
$6.15M Buy
56,799
+5,098
+10% +$528K 1.18% 19
2015
Q4
$5.31M Sell
51,701
-486
-0.9% -$48.9K 1.06% 20
2015
Q3
$4.87M Sell
52,187
-9,126
-15% -$883K 1.17% 14
2015
Q2
$5.98M Buy
61,313
+2,739
+5% +$274K 1.41% 9
2015
Q1
$5.89M Buy
58,574
+4,535
+8% +$461K 1.47% 7
2014
Q4
$5.65M Sell
54,039
-721
-1% -$76K 1.62% 5
2014
Q3
$5.84M Buy
54,760
+24,465
+81% +$2.54M 1.69% 3
2014
Q2
$3.17M Sell
30,295
-1,015
-3% -$103K 0.9% 24
2014
Q1
$3.08M Sell
31,310
-47
-0.1% -$4.36K 0.91% 26
2013
Q4
$2.87M Buy
31,357
+518
+2% +$47.7K 0.88% 29
2013
Q3
$2.67M Buy
30,839
+7,688
+33% +$690K 0.87% 33
2013
Q2
$1.99M Buy
+23,151
New +$1.96M 0.7% 45

Other funds holding JNJ

Calamos Wealth Management's JNJ Position: Q2 2026 in Review

Calamos Wealth Management reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q2 2026, selling an estimated $659K and leaving 118,126 shares worth $30M. The position accounts for 0.91% of the portfolio, ranked #23.

Calamos Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Calamos Wealth Management held 118,126 shares of Johnson & Johnson worth $30M as of Q2 2026.
  • Calamos Wealth Management sold 2,826 Johnson & Johnson shares in Q2 2026, an estimated $659K.
  • Johnson & Johnson made up 0.91% of Calamos Wealth Management's portfolio in Q2 2026, its #23 holding.
  • Calamos Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Calamos Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.